| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-15-1326 |
| P698 | PubMed publication ID | 27197161 |
| P50 | author | Ursula Klingmüller | Q41047364 |
| Torsten Goldmann | Q50033276 | ||
| Philippe Lucarelli | Q57046596 | ||
| Dmytro Dvornikov | Q57177039 | ||
| Sebastian Marwitz | Q80537804 | ||
| Heimo Mairbäurl | Q113110807 | ||
| P2093 | author name string | Reiner Siebert | |
| Martin Reck | |||
| Ole Ammerpohl | |||
| Klaus F Rabe | |||
| Marvin Wäsch | |||
| Ruth Merkle | |||
| Sofia Depner | |||
| Karin Müller-Decker | |||
| Ekkehard Vollmer | |||
| Christian Kugler | |||
| Magdalena Szczygieł | |||
| Swetlana Scheufele | |||
| Maren Kröger | |||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3785-3801 | |
| P577 | publication date | 2016-05-17 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion | |
| P478 | volume | 76 |
| Q92882068 | A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (BMP5) mRNA Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches |
| Q55409931 | Bone morphogenetic protein and activin membrane-bound inhibitor overexpression inhibits gastric tumor cell invasion via the transforming growth factor-β/epithelial-mesenchymal transition signaling pathway. |
| Q58798304 | Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway |
| Q59128432 | Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer |
| Q55453582 | Deregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression. |
| Q47168542 | Epigenetic modifications of the VGF gene in human non-small cell lung cancer tissues pave the way towards enhanced expression |
| Q38684032 | Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression |
| Q92528246 | Expression of the Major and Pro-Oncogenic H3K9 Lysine Methyltransferase SETDB1 in Non-Small Cell Lung Cancer |
| Q55426666 | Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response. |
| Q62632019 | Fountain of youth for squamous cell carcinomas? On the epigenetic age of non-small cell lung cancer and corresponding tumor-free lung tissues |
| Q90447900 | Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis |
| Q89718081 | Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis |
| Q97537508 | Identification key genes, key miRNAs and key transcription factors of lung adenocarcinoma |
| Q54118989 | Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis. |
| Q90705701 | Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis |
| Q52726915 | Identification of key differentially expressed genes associated with non‑small cell lung cancer by bioinformatics analyses. |
| Q64268084 | Interleukin-1β provided by KIT-competent mast cells is required for -mutant lung adenocarcinoma |
| Q52723729 | IκB Kinase α Is Required for Development and Progression of KRAS-Mutant Lung Adenocarcinoma. |
| Q41317042 | Lipidomes of lung cancer and tumour-free lung tissues reveal distinct molecular signatures for cancer differentiation, age, inflammation, and pulmonary emphysema |
| Q50102151 | Lipopolysaccharide enhances TGF-β1 signalling pathway and rat pancreatic fibrosis. |
| Q89537490 | Long Non-Coding RNA PVT1 Regulates BAMBI To Promote Tumor Progression In Non-Small Cell Lung Cancer By Sponging miR-17-5p |
| Q89583710 | MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer |
| Q64111704 | Novel methylation-driven genes identified as prognostic indicators for lung squamous cell carcinoma |
| Q37705651 | OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations |
| Q92381572 | Regulatory Network Analysis to Reveal Important miRNAs and Genes in Non-Small Cell Lung Cancer |
| Q50209869 | Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters. |
| Q64108520 | TGFβ-induced cytoskeletal remodeling mediates elevation of cell stiffness and invasiveness in NSCLC |
| Q89966156 | The Functional Effects of Key Driver KRAS Mutations on Gene Expression in Lung Cancer |
| Q89622529 | The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC |
| Q90724577 | Upregulated microRNA-106a Promotes Porcine Preadipocyte Proliferation and Differentiation by Targeting Different Genes |
| Q64088587 | Villi development core-related gene expression associated with lung squamous cancer prognosis |
| Q55513246 | WDR1 Promotes Cell Growth and Migration and Contributes to Malignant Phenotypes of Non-small Cell Lung Cancer through ADF/cofilin-mediated Actin Dynamics. |
Search more.